Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Scholar Rock Holding Corporation - Common Stock
(NQ:
SRRK
)
44.34
-0.58 (-1.29%)
Streaming Delayed Price
Updated: 4:00 PM EST, Jan 30, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Scholar Rock Holding Corporation - Common Stock
< Previous
1
2
3
4
5
6
Next >
Nasdaq Bears Dig In: Short Interest Hits Record 18.38 Billion Shares Amid Valuation Anxiety
December 24, 2025
As the final trading days of 2025 approach, the Nasdaq has reached a staggering milestone that has both bulls and bears on edge. According to the latest settlement data released on December 15, 2025,...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Stocks
Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away
↗
December 03, 2025
This investor just walked away as Scholar Rock heads into a pivotal 2026—here’s what that means for long-term shareholders.
Via
The Motley Fool
Topics
Regulatory Compliance
Top movers analysis one hour before the close of the markets on 2025-11-14: top gainers and losers in today's session.
↗
November 14, 2025
Here are the top movers in Friday's session, showcasing the stocks with significant price changes.
Via
Chartmill
Scholar Rock In Spotlight After FDA Refuses To Approve Muscular Atrophy Treatment Over Third-Party Manufacturing Facility Issues
↗
September 23, 2025
Via
Stocktwits
Why Is Scholar Rock Holding Stock Climbing Today?
↗
November 14, 2025
Scholar Rock shares jump after the company strengthened its cash runway into 2027 and advanced launch preparations for its lead drug candidate, apitegromab.
Via
Benzinga
Why Did Scholar Rock Soar 26% Today?
↗
November 14, 2025
The company is planning to reapply for approval of a muscle atrophy therapy in the coming year.
Via
Stocktwits
Topics
Earnings
Gold Tumbles Over 2%; Cidara Therapeutics Shares Spike Higher
↗
November 14, 2025
Via
Benzinga
Let's uncover which stocks are experiencing notable gaps during today's session.
↗
November 14, 2025
There are notable gap-ups and gap-downs in today's session. Let's take a look at which stocks are gapping on Friday.
Via
Chartmill
Legence, Cidara Therapeutics, Avadel Pharmaceuticals, Omeros And Other Big Stocks Moving Higher On Friday
↗
November 14, 2025
Via
Benzinga
Scholar Rock Holding Corp (NASDAQ:SRRK) Posts Wider-Than-Expected Q3 2025 Loss Amid Key Launch Preparations
↗
November 14, 2025
Scholar Rock invests heavily in its lead drug apitegromab, targeting a 2026 launch for spinal muscular atrophy despite a wider Q3 2025 loss.
Via
Chartmill
Looking For A Squeeze? Here Are The Top 10 Most Shorted Stocks
↗
November 13, 2025
Lucid, Avis, Hims & Hers Health and Upstart are some of the most heavily shorted stocks right now. Here's a look at the top ten.
Via
Benzinga
What to Expect from Scholar Rock Holding's Earnings
↗
November 13, 2025
Via
Benzinga
Earnings Scheduled For November 14, 2025
↗
November 14, 2025
Via
Benzinga
3 Beaten-Down Stocks With Rebound Potential This Earnings Season
↗
November 12, 2025
Via
MarketBeat
Alpha Buying: 3 Stocks With Sky-High Insider Confidence
↗
October 14, 2025
Via
Benzinga
Why Scholar Rock Stock Got Socked on Monday
↗
October 13, 2025
The biotech suffered a regulatory setback last month, and this new development might be another blow to its prospects.
Via
The Motley Fool
Topics
Earnings
Why Is Scholar Rock Stock Trading Lower On Monday?
↗
October 13, 2025
Scholar Rock stock falls as FDA issues Form 483 to Catalent; company to meet FDA, while apitegromab shows lean mass preservation in trial.
Via
Benzinga
Why Are Regeneron And Scholar Rock Shares Falling On Monday?
↗
October 13, 2025
Regeneron and Scholar Rock’s submissions have been delayed or denied following an FDA inspection at the third-party fill-finish facility Catalent Indiana, owned by Novo Nordisk.
Via
Stocktwits
12 Health Care Stocks Moving In Monday's Intraday Session
↗
October 13, 2025
Via
Benzinga
There are notable gap-ups and gap-downs in today's session.
↗
October 13, 2025
Via
Chartmill
Fastenal Posts Downbeat Earnings, Joins Vince Holding And Other Big Stocks Moving Lower In Monday's Pre-Market Session
↗
October 13, 2025
Via
Benzinga
Why Scholar Rock Stock Raced 6% Higher Today
↗
October 09, 2025
A pundit at an influential U.S. bank is quite bullish on the company's future.
Via
The Motley Fool
This Oracle Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday
↗
October 09, 2025
Via
Benzinga
Crinetics Pharmaceuticals, BlackBerry, Perpetua Resources And Other Big Stocks Moving Higher On Friday
↗
September 26, 2025
U.S. stocks were higher, with the Dow Jones index gaining more than 200 points on Friday. Shares of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose sharply during Friday's session after the FDA...
Via
Benzinga
Topics
Stocks
Scholar Rock's Spinal Muscular Atrophy Drug Faces FDA Delay Over Catalent Indiana Inspection
↗
September 23, 2025
FDA cites Catalent Indiana issues in Scholar Rock's SMA drug review; European approval decision expected in 2026, with Germany as the launch market.
Via
Benzinga
Scholar Rock, A Top 10% Stock, Dives After Catalent Issues Hamper SMA Drug
↗
September 23, 2025
Shares tumbled Tuesday after the FDA rejected the company's spinal muscular atrophy drug.
Via
Investor's Business Daily
Firefly Aerospace Posts Q2 Results, Joins Scholar Rock And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
↗
September 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
↗
September 23, 2025
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 22, 2025
Via
Benzinga
Curious about the stocks that are showing activity after the closing bell on Monday?
↗
September 22, 2025
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
Via
Chartmill
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
